COPD patients to have better safety against pneumonia with new vaccine A new vaccine against pneumonia may offer better protection from chronic obstructive pulmonary disease patients than the currently accepted vaccine, according to latest research that will be posted in the September 15 issue of the American Journal of the Respiratory and Important Care Journal, a publication of the American Thoracic Society www.modafinilreview.net/modafinil-and-weight-loss.html . Because pneumonia disproportionately affects patients with COPD and sometimes causes exacerbations, the Centers for Disease Control presently advise that all adults with COPD receive the 23-valent pneumococcal polysaccharide vaccination .
clinically approved medication
CPS staff and college students received EAIs for acute allergic reactions Over fifty % of college students who used the emergency medication had no known history of allergic reaction During the 2012-2013 school year, 38 Chicago General public School learners and staff received emergency medication for potentially life-threatening allergic reactions. Following nationwide and regional legislation, CPS was the first large, urban school district in the nation to develop and put into action an initiative to supply all general public and charter academic institutions in Chicago with epinephrine auto-injectors – – medical devices used to take care of acute allergic reactions.